BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

...Separately, studies in mice by a group at University of South Dakota Sanford School of Medicine...
BioCentury | Jun 4, 2019
Distillery Therapeutics

PDE-1 inhibition could treat heart failure

...published online May 22, 2019 doi:10.1126/sciadv.aaw5870 CONTACT: Xuejun Wang, University of South Dakota Sanford School of Medicine, Vermillion, S.D. email: xuejun.wang@usd.edu Claire Quang University of South Dakota Sanford School of Medicine Phosphodiesterase-1...
Items per page:
1 - 2 of 2
BioCentury | Oct 16, 2020
Product Development

Recent Phase III disappointment aside, the heart failure pipeline holds plenty to look forward to

...Separately, studies in mice by a group at University of South Dakota Sanford School of Medicine...
BioCentury | Jun 4, 2019
Distillery Therapeutics

PDE-1 inhibition could treat heart failure

...published online May 22, 2019 doi:10.1126/sciadv.aaw5870 CONTACT: Xuejun Wang, University of South Dakota Sanford School of Medicine, Vermillion, S.D. email: xuejun.wang@usd.edu Claire Quang University of South Dakota Sanford School of Medicine Phosphodiesterase-1...
Items per page:
1 - 2 of 2